Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Autor: Gupta, Mamta *, Maurer, Matthew J., Wellik, Linda E., Law, Mark E., Han, Jing Jing, Ozsan, Nazan, Micallef, Ivana N., Dogan, Ahmet, Witzig, Thomas E.
Zdroj: In Blood 22 November 2012 120(22):4400-4406
Databáze: ScienceDirect